Lysergide

Lysergide, also known as lysergic acid diethylamide (LSD), is a semi-synthetic hallucinogen and one of the most potent psychoactive substances known. It was first synthesized in 1938 by Albert Hofmann at Sandoz Laboratories. Lysergide is an ergoline alkaloid derived from lysergic acid, which itself is produced from ergot alkaloids found in the fungus Claviceps purpurea. The drug acts primarily as an agonist at serotonin receptors, especially 5HT2A and 5HT2C, but also activates other serotonin receptor subtypes (including 5HT1A, 5HT1B, 5HT1D, 5HT5A, 5HT6 and 5HT7), as well as dopamine and norepinephrine receptors. Its hallucinogenic effects are mainly attributed to its action on the serotonin system. Lysergide was marketed under the brand name Delysid for psychiatric research and therapeutic purposes during the mid-twentieth century but is now internationally controlled due to its high potential for abuse[1][2][3][4][5][6].

Brand names

Delysid

Other names

lysergic acid diethylamideLSDd-LSDDelysid